Common Stock, Shares Authorized of NeuroSense Therapeutics Ltd. from 31 Dec 2022 to 30 Jun 2025

Taxonomy & unit
us-gaap: shares
Description
The maximum number of common shares permitted to be issued by an entity's charter and bylaws.
Summary
NeuroSense Therapeutics Ltd. quarterly Common Stock, Shares Authorized in shares history and change rate from 31 Dec 2022 to 30 Jun 2025.
  • NeuroSense Therapeutics Ltd. Common Stock, Shares Authorized for the quarter ending 30 Jun 2025 was 90,000,000, a 50% increase year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares Authorized, Quarterly (shares)
Common Stock, Shares Authorized, YoY Quarterly Change (%)

NeuroSense Therapeutics Ltd. Quarterly Common Stock, Shares Authorized (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q2 2025 90,000,000 +30,000,000 +50% 30 Jun 2025 6-K 01 Aug 2025 2025 Q2
Q4 2024 90,000,000 +30,000,000 +50% 31 Dec 2024 6-K 01 Aug 2025 2025 Q2
Q2 2024 60,000,000 30 Jun 2024 6-K 30 Sep 2024 2024 Q2
Q4 2023 60,000,000 0 0% 31 Dec 2023 20-F 07 Apr 2025 2024 FY
Q4 2022 60,000,000 31 Dec 2022 6-K 17 Jun 2024 2023 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.